Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-20-000979

Director acquired 5,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fink Jeffrey Arvin Director 2020-12-16 Option exercise +5,625 6,562 D
Derivatives
Fink Jeffrey Arvin Director 2020-12-16 Option exercise · Restricted Stock Unit +5,625 5,625 D
Loading xslF345X03/doc4_6962.xml…